1Merkel F, Pullin O, Marx M, et al. Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease:Report of 35 cases. Nephrol Dial Transplant,1994, 9(4) :372-376.
2Ang C, Savige J, Dawborn J, et al. Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant, 1998,13 (4): 935-939.
3Salama AD, Levy JB, Lightstone L, et al. Goodpasture' s disease. Lancet,2001,358(9285) :917-920.
4Jindal KK. Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendation. Kidney Int, 1999,70(suppl): s33-s40.
5Daly C, Conlon PJ, Medwar W, et al. Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience.Renal Failure, 1996,18 ( 1 ): 105-112.
6Falk R J, Jennette C, Nachman PH. Primary glomerular disease. In: Brenner BM, eds. Brenner and Rector' s the Kidney, volume Ⅱ, 6th ed.Philadelphia, Saunders ,2001. 1263-1349.
